SHARON MCEVOY: Open Payments
NPI 1134382484 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 2 | $52 |
| Dexcom, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $48 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: UNITHROID, Dexcom G6 Transmitter, REZDIFFRA, IQIRVO, Ozempic, Rybelsus, MOUNJARO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
